Head-to-head comparison
SexyMD vs The Edit
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
SexyMD publishes every plan length before intake and names the professional entities behind its prescriptions, but the $199 in each headline is a 48-week commitment rate.
From $269/mo sema · From $369/mo tirz · Verified September 2026
Marked down on: Every headline quotes $199 and $299, which are the 48-week rates, not the four-week ones.
Desk Score
The Edit names its pharmacy with an address and its prescriber with an NPI you can check, and prints its first-month rates larger than the standing prices they precede.
From $259/mo sema · From $349/mo tirz · Verified September 2026
Marked down on: The $200 and $300 first-order rates are printed larger than the standing $259 and $349, with no end date on the offer.
The Edit takes this head-to-head with the higher Desk Score, 79/100 (C+) against 74/100 (C) for SexyMD. SexyMD still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
SexyMD
74/100
C
The Edit
79/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | SexyMD | The Edit |
|---|---|---|
| Semaglutide | From $269/moFrom $269/mo (28-day cycle, compounded) | From $259/moFrom $259/mo (compounded) |
| Tirzepatide | From $369/moFrom $369/mo (28-day cycle, compounded) | From $349/moFrom $349/mo (compounded) |
| Coverage | 47 states (not Arkansas, Mississippi or New Jersey) | All 50 states claimed, no list published |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Anyone who will check the plan length behind a headline before comparing it with anything else. | Anyone who wants a checkable prescriber and a named pharmacy, and will budget on month two. |
| Desk Score | 74/100C | 79/100C+ |
The verdict
Desk pick — The EditThe Edit takes this head-to-head with the higher Desk Score, 79/100 (C+) against 74/100 (C) for SexyMD. SexyMD still holds its ground where its strengths line up with yours.
Choose SexyMD if…
Anyone who will check the plan length behind a headline before comparing it with anything else.
From $269/mo sema · From $369/mo tirz · 47 states (not Arkansas, Mississippi or New Jersey)
Choose The Edit if…
Anyone who wants a checkable prescriber and a named pharmacy, and will budget on month two.
From $259/mo sema · From $349/mo tirz · All 50 states claimed, no list published
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: SexyMD · The Edit.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs SexyMD
- CoreAge Rx vs The Edit
- Peak Wellness vs SexyMD
- Enhance MD vs The Edit
- SexyMD vs Tryozi
- Peak Wellness vs The Edit
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.